alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     </LEGEND>
                         
                        


       
<S>                             <C>
<PERIOD-TYPE>                   3-mos
<FISCAL-YEAR-END>                              dec-31-1996
                            
<PERIOD-END>                                   sep-30-1996
<CASH>                                         2,078,640
<SECURITIES>                                   0
<RECEIVABLES>                                  1,021,079
<ALLOWANCES>                                   0
<INVENTORY>                                    706,318
<CURRENT-ASSETS>                               3,928,417
<PP&E>                                         887,618
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 8,020,436
<CURRENT-LIABILITIES>                          2,215,605
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    225
<COMMON>                                       92
<OTHER-SE>                                     5,460,868
<TOTAL-LIABILITY-AND-EQUITY>                   8,020,436
<SALES>                                        5,774,192
<TOTAL-REVENUES>                               5,774,192
<CGS>                                          5,012,435
<TOTAL-COSTS>                                  2,149,606
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             8,119
<INCOME-PRETAX>                                (1,395,968)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (1,395,968)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (1,395,968)
<EPS-PRIMARY>                                  (1.51)
<EPS-DILUTED>                                  (1.51)
        


</TABLE>
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

Harold Perritt,

Plaintiff,

v.

C. R. Bard, Inc., et al.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-16-00521-PHX-DGC

APPEARANCE OF COUNSEL

To: The clerk of court and all parties of record

I am admitted or otherwise authorized to practice in this court, and I appear in this case as counsel for:

Defendants C. R. Bard, Inc. and Bard Peripheral Vascular, Inc.

Date: March 2, 2016 /s/ Richard B. North, Jr.

Attorney's signature

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed name and bar number

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6000

Telephone number

(404 322-6050

FAX number

Case 2:15-md-02641-DGC Document 949 Filed 03/04/16 Page 1 of 1
<PAGE>   1

                                  EXHIBIT 11.1

                    RESOURCE BANCSHARES MORTGAGE GROUP, INC.
           STATEMENT RE: COMPUTATION OF NET INCOME PER COMMON SHARE,
                      BASIC AND DILUTED EARNINGS PER SHARE

                   ($ in thousands, except per share amounts)

                                                        For the Quarter
                                                      Ended March 31, 1999
                                                   ---------------------------

Net income                                                 $ 11,161

Net income per common share - basic (1)                    $   0.50

Net income per common share - diluted (2)                  $   0.50

1) The number of common shares outstanding used to compute net income per
share-basic was 22,224,610 for the quarter ended March 31, 1999.

2) Diluted earnings per common share for the quarter ended March 31, 1999, was
calculated based on weighted average common shares outstanding of 22,477,224,
which assumes the exercise of options covering 1,100,705 shares and computes
incremental shares using the treasury stock method.
----

----

|   | (1) | to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|                    |   |   |                                         |   |
|-------------------------|--------|--------|----------------------------------------------|--------|
| Dated: February 9, 2011 |   |   | /s/ Warren Bielke                            |   |
|                    |   |   | Warren BielkeInterim Chief Executive Officer |   |

| Dated: February 9, 2011 |   |   | /s/ Katherine L. Wolf                                                  |   |
|-------------------------|--------|--------|------------------------------------------------------------------------|--------|
|                    |   |   | Katherine L. WolfChief Financial Officerand EVP, Corporate Development |   |
INTERPHARM
          HOLDINGS, INC
 (In
          thousands, except per share data)


**Exhibit
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**








Each
      of
      the undersigned hereby certifies, in his capacity as an officer of Interpharm
      Holdings, Inc. (the “Company”), for the purposes of 18 U.S.C. Section 1350, as
      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
      the
      best of his knowledge:





(1)  The
      Quarterly Report of the Company on Form 10-Q for the period ended September
      30,
      2006 fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





Dated:
      November 14, 2006





/s/
      Cameron Reid


--------------------------------


Cameron
      Reid


Chief
      Executive Officer





/s/
      George Aronson


--------------------------------


George
      Aronson


Chief
      Financial Officer





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      Interpharm Holdings, Inc. and will be retained by Interpharm Holdings, Inc.
      and
      furnished to the Securities and Exchange Commission or its staff upon
      request.




40
Administrative Office of the United States Courts FOR COURT USE ONLY

TRANSCRIPT ORDER

DUE DATE:

2AO 435

AZ Form (Rev. )

1. NAME 2. PHONE NUMBER 3. DATE

4. FIRM NAME

5. MAILING ADDRESS 6. CITY 7. STATE 8. ZIP CODE

9. CASE NUMBER 10. JUDGE DATES OF PROCEEDINGS

11. 12. 

13. CASE NAME LOCATION OF PROCEEDINGS

14. 15. STATE

16. ORDER FOR

APPEAL CRIMINAL

NON-APPEAL CIVIL

CRIMINAL JUSTICE ACT

IN FORMA PAUPERIS

BANKRUPTCY

OTHER 6SHFLI\

17. TRANSCRIPT REQUESTED (Specify portion(s) and date(s) of proceeding(s) for which transcript is requested)

PORTIONS DATE(S) PORTION(S) DATE(S)

TESTIMONY (6SHFLI\

PRE-TRIAL PROCEEDING

OTHER (6SHFLI\)

VOIR DIRE

OPENING STATEMENT (Plaintiff)

OPENING STATEMENT (Defendant)

CLOSING ARGUMENT (Plaintiff)

CLOSING ARGUMENT (Defendant)

OPINION OF COURT

JURY INSTRUCTIONS

SENTENCING

BAIL HEARING

18. ORDER

CATEGORY

ORIGINAL + 1

(original to Court,

copy to ordering party)

FIRST

COPY

# OF

ADDITIONAL

COPIES

DELIVERY INSTRUCTIONS

(&heck all that apply) ESTIMATED COSTS

30 DAYS   PAPER COPY

3')HPDLO

$6&,,HPDLO

14 DAYS  

7 DAYS  

DAILY  

HOURLY  

REALTIME  

CERTIFICATION (19. & 20.)

By signing below, I certify that I will pay all charges

(deposit plus additional).

E-MAIL ADDRESS

NOTE: IF ORDERING 025(7+$121()250$7,

THERE WILL BE AN ADDITIONAL CHARGE.

19. SIGNATURE

20. DATE

TRANSCRIPT TO BE PREPARED BY

ESTIMATE TOTAL

PROCESSED BY PHONE NUMBER

ORDER RECEIVED DATE BY

DEPOSIT PAID DEPOSIT PAID

TRANSCRIPT ORDERED TOTAL CHARGES

TRANSCRIPT RECEIVED LESS DEPOSIT

ORDERING PARTY NOTIFIED

TO PICK UP TRANSCRIPT

TOTAL REFUNDED

PARTY RECEIVED TRANSCRIPT TOTAL DUE

DISTRIBUTION: COURT COPY TRANSCRIPTION COPY ORDER RECEIPT ORDER COPY

Amanda Sheridan 602.382.6304 11/20/17

Snell & Wilmer LLP

400 E. Van Buren Phoenix AZ 85004

2:15-md-02641 DGC 11/17/17

Bard IVC Filters Products Liability Litigation Phoenix AZ

✔

✔

Status Conference 11/17/17

✔ ✔

asheridan@swlaw.com

s/ Amanda C. Sheridan

November 20, 2017

Case 2:15-md-02641-DGC Document 8862 Filed 11/20/17 Page 1 of 1
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"Dacia Massengill","author_url":"https:\/\/www.nasa.gov\/author\/daciamassengill-2\/","title":"NISAR Mission","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kaV2WHopt1\"><a href=\"https:\/\/www.nasa.gov\/event\/nisar\/\">NISAR Mission<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/event\/nisar\/embed\/#?secret=kaV2WHopt1\" width=\"600\" height=\"338\" title=\"“NISAR Mission” — NASA\" data-secret=\"kaV2WHopt1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.nasa.gov\/wp-content\/uploads\/2023\/05\/missionswebnisar-pgkg4tl.original.jpg?w=600","thumbnail_width":600,"thumbnail_height":322}
SHARON KELLER

 PRESIDING JUDGE

LAWRENCE E. MEYERS

CHERYL JOHNSON

MIKE KEASLER

BARBARA P. HERVEY

ELSA ALCALA

BERT RICHARDSON

KEVIN P. YEARY

DAVID NEWELL

 JUDGES

COURT OF CRIMINAL APPEALS

P.O. BOX 12308, CAPITOL STATION

AUSTIN, TEXAS 78711

ABEL ACOSTA

CLERK

(512) 463-1551

SIAN SCHILHAB

GENERAL COUNSEL

(512) 463-1597

SUPREME COURT BUILDING, 201 WEST 14TH STREET, ROOM 106, AUSTIN, TEXAS 78701

WEBSITE WWW.TXCOURTS.GOV/CCA.ASPX

Friday, October 09, 2015

Michael Mowla

Attorney at Law

P. O. Box 868

Cedar Hill, TX 75106

* DELIVERED VIA E-MAIL *

Charles "Chad" Baruch

3308 Grove Avenue

Dallas, TX 75204

* DELIVERED VIA E-MAIL *

George Rankin Milner III

Milner * Finn * Price

2828 N Harwood St., Suite 1950

Dallas, TX 75201-2143

* DELIVERED VIA E-MAIL *

L. T. Bradt

14015 Southwest Freeway

Suite 4

Sugar Land, TX 77478

* DELIVERED VIA E-MAIL *

Re: HILL, ALBERT G.

CCA Nos. PD-0019-15, PD-0020-15, PD-0021-15, PD-0022-15

Dear Counselors:

The above-styled cases are set for submission on Wednesday, November 04, 2015, at 9:00 AM. 

Please notify this Court within 10 days of the date of this notice whether you will appear for oral

argument. 

Failure to respond constitutes waiver of oral argument

Please let us know if you have any questions.

Sincerely,

_____________________________

Abel Acosta, Clerk

cc: Robert Udashen (DELIVERED VIA E-MAIL)

District Attorney Dallas County (DELIVERED VIA E-MAIL)

Brett E. Ordiway (DELIVERED VIA E-MAIL)

Lisa McMinn (DELIVERED VIA E-MAIL)

FILE COPY
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

Michael Conlin,

Plaintiff,

v.

C. R. Bard Inc. and Bard Peripheral 

Vascular, Inc.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-17-03733-PHX-DGC

WAIVER OF THE SERVICE OF SUMMONS

To: Freese & Goss PLLC - Birmingham, AL

(Name of plaintiff’s attorney or unrepresented plaintiff)

I have received your request to waive service of a summons in this action along with a copy of the complaint, two 

copies of this waiver form, and a prepaid means of returning one signed copy of the form to you.

I, or the entity I represent, agree to save the expense of serving a summons and complaint in this case.

I understand that I, or the entity I represent, will keep all defenses or objections to the lawsuit, the court’s 

jurisdiction, and the venue of the action, but that I waive any objections to the absence of a summons or of service.

I also understand that I, or the entity I represent, must file and serve an answer or a motion under Rule 12 within 

60 days from 11/14/2017, the date when this request was sent (or 90 days if it was sent outside the United States). If I fail 

to do so, a default judgment will be entered against me or the entity I represent.

Date: November 27, 2017 /s/ Richard B. North, Jr.

Signature of the attorney or unrepresented party

C. R. Bard, Inc. and Bard Peripheral

Vascular, Inc.

Printed name of parties waiving service of 

summons

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed Name

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6155

Telephone number

Duty to Avoid Unnecessary Expenses of Serving a Summons

Rule 4 of the Federal Rules of Civil Procedure requires certain defendants to cooperate in saving unnecessary expenses of serving a 

summons and complaint. A defendant who is located in the United States and who fails to return a signed waiver of service requested by a plaintiff 

located in the United States will be required to pay the expenses of service, unless the defendant shows good cause for the failure. 

“Good cause” does not include a belief that the lawsuit is groundless, or that it has been brought in an improper venue, or that the court has 

no jurisdiction over this matter or over the defendant or the defendant’s property. 

If the waiver is signed and returned, you can still make these and all other defenses and objections, but you cannot object to the absence of 

a summons or of service. 

If you waive service, then you must, within the time specified on the waiver form, serve an answer or a motion under Rule 12 on the 

plaintiff and file a copy with the court. By signing and returning the waiver form, you are allowed more time to respond than if a summons had been 

served.

Case 2:15-md-02641-DGC Document 9124 Filed 12/05/17 Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          22,716
<INT-BEARING-DEPOSITS>                         129,039
<FED-FUNDS-SOLD>                                39,933
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    367,819
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                      1,097,815
<ALLOWANCE>                                     20,227
<TOTAL-ASSETS>                               1,725,660
<DEPOSITS>                                   1,505,747
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                             56,663
<LONG-TERM>                                     12,650
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           101
<OTHER-SE>                                     150,499
<TOTAL-LIABILITIES-AND-EQUITY>               1,725,660
<INTEREST-LOAN>                                 56,345
<INTEREST-INVEST>                                9,466
<INTEREST-OTHER>                                 8,796
<INTEREST-TOTAL>                                74,607
<INTEREST-DEPOSIT>                              41,655
<INTEREST-EXPENSE>                              42,273
<INTEREST-INCOME-NET>                           32,334
<LOAN-LOSSES>                                      750
<SECURITIES-GAINS>                               2,691
<EXPENSE-OTHER>                                 17,592
<INCOME-PRETAX>                                 23,450
<INCOME-PRE-EXTRAORDINARY>                      23,450
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    14,750
<EPS-BASIC>                                       1.58
<EPS-DILUTED>                                     1.56
<YIELD-ACTUAL>                                    3.21
<LOANS-NON>                                     32,991
<LOANS-PAST>                                     1,851
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                21,411
<CHARGE-OFFS>                                    1,977
<RECOVERIES>                                        43
<ALLOWANCE-CLOSE>                               20,227
<ALLOWANCE-DOMESTIC>                             9,356
<ALLOWANCE-FOREIGN>                             10,871
<ALLOWANCE-UNALLOCATED>                         20,227


</TABLE>
PORTAGE PARTNERS, LTD.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF CASH FLOWS

                                     For the years ended        August 18, 1999
                                     June 30,                    (Inception) to
                                     2004              2003       June 30, 2004
CASH FLOWS
FROM
OPERATING
ACTIVITIES
Net (loss)                   $(805)                  $(460)            $(7,727)
Increase in
accounts
payable                      805                       460              3,152

Net cash
(used) by
operating
activities                     -                             -          (2,575)

CASH FLOWS
FROM
FINANCING
ACTIVITIES
Proceeds from
stock issuances         -                             -              2,575

Net cash
provided by
financing
activities                    -                            -              2,575

Net increase
in cash                                                                       -
Cash   beginning                                                          -
Cash   ending                                                               -

Supplemental
disclosures:
Interest paid              -                                  -               -
Income taxes
paid                          -                                 -             -

Non-cash
transactions:
Shares issued
for dividend                -                                 -          $2,000

Number of
shares issued            -                                -         2,000,000
for dividend

The accompanying notes are an intregal part of these financial statements.
Page 1
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, Robert B. Goergen, Chairman and Chief Executive Officer ofBlyth, Inc., certifythat: 

 

1.                 I have reviewed this annual report on Form 10-K of Blyth,Inc.; 

 

2.                 Based on my knowledge, this report does not contain anyuntrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by thisreport; 

 

3.                 Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this report; 

 

4.                The registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrantand have: 

 

(a) Designed such disclosure controls and procedures,or caused such disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to the registrant,including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this report is beingprepared; 

 

(b) Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of theend of the period covered by this report based on such evaluation; and 

 

(c) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarterin the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and 

 

5.                 The registrant’s other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the audit committee ofthe registrant’s board of directors (or persons performing the equivalentfunctions): 

 

(a) All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and 

 

(b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’sinternal control over financial reporting. 

 
| Date: April 30, 2004            |
|--------------------------------------|
|                                 |
|                                 |
| /s/  Robert B. Goergen               |   |
| Robert B. Goergen                    |
| Chairman and Chief Executive Officer |

 

----